Literature DB >> 30176039

Direct Immunofluorescence of Mechanobullous Epidermolysis Bullosa Acquisita, Porphyria Cutanea Tarda and Pseudoporphyria.

Heleen J de Groot1, Marcel F Jonkman, Hendri H Pas, Gilles F H Diercks.   

Abstract

Mechanobullous epidermolysis bullosa acquisita (mEBA) can have a clinical presentation that is very similar to other blistering diseases, such as porphyria cutanea tarda (PCT) and pseudoporphyria. Direct immunofluorescence is an important feature in the diagnosis of mEBA, although features that overlap with PCT and pseudoporphyria have been reported. This retrospective observational study investigated whether direct immunofluorescence can discriminate mEBA from PCT and pseudoporphyria. Biopsies of 13 patients with mEBA, 10 with PCT and 10 with pseudoporphyria were included. In 7 cases of PCT and 4 of pseudoporphyria, direct immunofluorescence showed a pattern at the dermal-epidermal junction that appeared similar to the u-serrated pattern in mEBA. Vessel wall depositions were observed in all 3 diseases, but were more frequent and more intense in PCT and pseudoporphyria than in mEBA. Careful examination of direct immunofluorescence of mEBA vs. PCT and pseudoporphyria revealed different staining patterns, although overlapping features were present. Therefore, integrating all clinical and laboratory data is essential to differentiate between mEBA, PCT and pseudoporphyria.

Entities:  

Keywords:  directimmunofluorescencemicroscopy; mechanobullousepidermolysisbullosaacquisita; porphyriacutaneatarda; pseudoporphyria

Mesh:

Substances:

Year:  2019        PMID: 30176039     DOI: 10.2340/00015555-3021

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  2 in total

1.  Blisters and Crusts on the Dorsum of the Hands: A Quiz.

Authors:  Benjamin Klein; Jan Christoph Simon; Konstantin Dumann; Regina Treudler
Journal:  Acta Derm Venereol       Date:  2021-08-31       Impact factor: 3.875

2.  Epidermolysis bullosa acquisita.

Authors:  Denise Miyamoto; Juliana Olivieri Gordilho; Claudia Giuli Santi; Adriana Maria Porro
Journal:  An Bras Dermatol       Date:  2022-06-11       Impact factor: 2.113

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.